Golden Throat Holdings Group Company Limited
HKSE: 6896.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Yong Zeng
- Employees
- 874
- Headquarters
- Liuzhou, China
- IPO year
- 2015
- Market cap
- HK$2.6B
- Website
- https://www.goldenthroat.com
Loading 6896…
Loading profile data…Frequently asked questions about 6896
What does Golden Throat Holdings Group Company Limited (6896.HK) do?
Golden Throat Holdings Group Company Limited, an investment holding company, manufactures and sells pharmaceutical, healthcare food, and other products in the People's Republic of China. It offers Golden Throat lozenges over-the-counter medicine to relive symptoms of sore and dry throat, and hoarse voice caused by acute pharyngitis. It also prov...
Where does 6896.HK trade?
Golden Throat Holdings Group Company Limited (6896.HK) trades on the Hong Kong Stock Exchange.
What sector is 6896.HK in?
Golden Throat Holdings Group Company Limited (6896.HK) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Golden Throat Holdings Group Company Limited?
Yong Zeng is the chief executive officer of Golden Throat Holdings Group Company Limited (6896.HK).
Where is Golden Throat Holdings Group Company Limited headquartered?
Golden Throat Holdings Group Company Limited is headquartered in China.
Does 6896.HK pay a dividend?
Yes — Golden Throat Holdings Group Company Limited (6896.HK) paid a trailing twelve-month dividend of HKD 0.50 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 6896.HK go public?
Golden Throat Holdings Group Company Limited (6896.HK) completed its initial public offering in 2015.